Immunotherapy in ovarian cancer: where are we now, and where are we going?

Clin Adv Hematol Oncol. 2017 Nov;15(11):851-853.
No abstract available

Publication types

  • Interview

MeSH terms

  • Cancer Vaccines / therapeutic use
  • Female
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods*
  • Ovarian Neoplasms / immunology
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / therapy*
  • Ovary / immunology
  • Ovary / pathology

Substances

  • Cancer Vaccines